The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,464.00
Bid: 12,462.00
Ask: 12,466.00
Change: 60.00 (0.48%)
Spread: 4.00 (0.032%)
Open: 12,500.00
High: 12,514.00
Low: 12,444.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Thomas Cook Up As China's Fosun Takes Stake

Fri, 06th Mar 2015 11:37

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Friday.
-------
FTSE 100 WINNERS
-------
Weir Group, up 6% at 1,831.7 pence. The oil and gas service company's shares are rising on press reports about speculation that it could attract a bid from a US private equity firm. The Independent said that GE Capital is being linked with making a 2,800.00 pence per share bid, though it does attribute this to "starry-eyed punters".

ITV, up 1.2% at 244p. Liberum has raised the broadcaster's price target to 310p from 255p, keeping its Buy rating. The broadcaster shares have risen around 7% in the past week as several brokers have lifted price targets and recommendations. Goldman Thursday included the company in its "Conviction Buy List", with its price target at 284p from 253p, while JP Morgan raised its price target for the group to 251p from 243p, with a Overweight rating.
-------
FTSE 100 LOSERS
-------
Fresnillo, down 1.8%, Randgold Resources, down 1.5%. The gold miners are suffering from the weakness in precious metal prices, which have fallen over the last four days. Gold is down at USD1,196.85 Friday morning.

Anglo American, down 1.0%, and Rio Tinto, down 0.7%. Iron ore prices have fallen to a fresh six-year low of USD59.30 a tonne, according to reports. Rio also said Friday that it has increased its reserves in the Diavik diamond project, the Pilbara iron project and the Hail Creek Coal project.

AstraZeneca, down 1.0%. The pharmaceutical giant guided that it expects its total revenue to decline by a mid-single digit percentage at constant exchange rates in 2015, in line with previous sales revenue guidance it gave at the time of its full-year results. AstraZeneca said that based on current exchange rates, total revenue is expected to decline by low double-digit percent at actual exchange rates, and core earnings per share is expected to be broadly in line with 2014.
-------
FTSE 250 WINNERS
-------
Thomas Cook Group, up 19%. The travel operator said it has struck a strategic deal with Chinese investment group Fosun International under which the latter will acquire a 5% stake in Thomas Cook, or 73.1 million shares, for GBP91.8 million. The shares are valued at 125.58 pence, compared to the travel firm's closing price Thursday of 120.60p. Fosun, which recently bought France's Club Med, will also raise its stake to 10% by buying more shares in the open market. Shore Capital says the deal is a good one for Thomas Cook.

Afren, up 10%. The troubled oil and gas company, which will be relegated from the FTSE 250 on March 23, is looking to China to bring in "substantial" new capital in the form of new equity, the Financial Times reported. Ethelbert Cooper, the Liberian entrepreneur who founded Afren, plans to recapitalize the company in partnership with a consortium of Chinese investors. This will become the first Africa-China partnership in the oil and gas sector listed in the UK.
-------
FTSE 250 LOSERS
-------
Just Retirement Group, down 7% at 162.3p. Permira, the principal shareholder of Just Retirement Group, has sold around 50 million shares or a 10% stake in the company at a price of 162 pence per share through a secondary placing with institutional investors, raising GBP81 million for the private equity company. Permira had a 62.27% interest in the annuities provider, and that will fall to about 52%.
-------
AIM ALL-SHARE WINNERS
-------
Snoozebox Holdings, up 14%. The portable accommodation company confirmed media speculation that it has been selected to work on the Ealing Council tender for modular accommodation in London. Snoozebox said it, along with support services company Mears Group, has been selected to provide turnkey modular serviced accommodation as part of the Ealing Council tender for an immediate short-term housing solution.
-------
AIM ALL-SHARE LOSERS
-------
Daniel Stewart Securities, off 29%. The institutional stockbroker, wealth manager and corporate advisory's shares have been restored to trading following the publication of its restated results for 2014. The company got into difficulties last year after it identified a shortfall in regulatory capital, and its shares were suspended as it sought new funding to strengthen its balance sheet. The group in January said it has secured GBP1.5 million in new funding through two cash subscriptions and via a loan note agreement.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.